The Patent Finder
NB

Nchroma Bio, Inc.

First filing 2023
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Three patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in May 2044. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2044
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2025 to 2044.
US 12,390,538 Compositions and Methods for Epigenetic Regulation of HBV Gene Expression May 15, 2044
US 12,558,437 Compositions and Methods for Epigenetic Regulation of HBV Gene Expression May 15, 2044
US 12,649,003 Compositions and Methods for Epigenetic Regulation of HBV Gene Expression May 15, 2044
20292033203720412044
21 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 3 of 3

PatentTitleStatusExpiresConfidence
US 12,390,538Compositions and Methods for Epigenetic Regulation of HBV Gene Expression
In force
 · Medium confidence
In forceMedium confidence
US 12,558,437Compositions and Methods for Epigenetic Regulation of HBV Gene Expression
In force
 · Medium confidence
In forceMedium confidence
US 12,649,003Compositions and Methods for Epigenetic Regulation of HBV Gene Expression
In force
 · Low confidence
In forceLow confidence
Also on record, not counted in the 3: 21 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited